SCHEMBL30487566

SCHEMBL30487566

Oc1ccccc1CNc1ncnc2nc[nH]c12

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 7/20 0.72
HTT P42858 5/20 0.72
ALOX15 P16050 2/20 0.72
SMN1; SMN2 Q16637 6/20 0.67
TSHR P16473 4/20 0.67
TP53 P04637 2/20 0.67
HSD17B10 Q99714 2/20 0.67
MAPK1 P28482 4/20 0.67
CYP1A2 P05177 3/20 0.67
CDK2 P24941 2/20 0.67
CYP2D6 P10635 1/20 0.67
RECQL P46063 1/20 0.62
KDR P35968 2/20 0.57
MEN1 O00255 1/20 0.57
ADORA3 P0DMS8 1/20 0.57
KMT2A Q03164 1/20 0.57
HIF1A Q16665 1/20 0.57
TAAR1 Q96RJ0 1/20 0.56
PRMT1 Q99873 1/20 0.56
MAPT P10636 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL786294 1.00 LMNA (0.72) LMNAHTTALOX15SMN1; SMN2TSHR
SCHEMBL30115192 1.00 LMNA (0.72) LMNAHTTALOX15SMN1; SMN2TSHR
SCHEMBL30320040 0.93 LMNA (0.63) LMNAHTTALOX15SMN1; SMN2TSHR
SCHEMBL16147218 0.91 LMNA (0.67) LMNAHTTALOX15SMN1; SMN2TSHR
SCHEMBL25173744 0.86 SMN1; SMN2 (0.70) LMNAHTTALOX15SMN1; SMN2TSHR
SCHEMBL4927149 0.85 LMNA (0.74) LMNAHTTALOX15SMN1; SMN2TSHR
SCHEMBL4924010 0.85 LMNA (0.64) LMNAHTTALOX15SMN1; SMN2TSHR
SCHEMBL640426 0.84 LMNA (0.58) LMNAHTTALOX15SMN1; SMN2TSHR
SCHEMBL4913694 0.84 LMNA (0.65) LMNAHTTALOX15SMN1; SMN2TSHR
SCHEMBL4922655 0.84 LMNA (0.58) LMNAHTTALOX15SMN1; SMN2TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12570657-B2 Mesylate salts of heterocyclic cytokinins, compositions containing these derivatives and use thereof UNIVERZITA PALACKEHO V OLOMOUCI (CZ) 2026-03-10 US disclosed
CN-119344334-A Compositions comprising recombinant bacillus cells and other biocontrol agents 巴斯夫公司 2025-01-24 CN disclosed
CN-119241718-A Fusion proteins and methods for stimulating plant growth, protecting plants, and immobilizing bacillus spores on plants 斯波根生物技术公司 2025-01-03 CN disclosed
CN-119157144-A Compositions comprising recombinant bacillus cells and pesticides 巴斯夫公司 2024-12-20 CN disclosed
CN-107205404-B Compositions comprising recombinant bacillus cells and other biocontrol agents 巴斯夫公司 2024-08-09 CN disclosed
CN-106998695-B Compositions comprising recombinant bacillus cells and pesticides 巴斯夫公司 2024-08-06 CN disclosed
US-20230192697-A1 MESYLATE SALTS OF HETEROCYCLIC CYTOKININS, COMPOSITIONS CONTAINING THESE DERIVATIVES AND USE THEREOF UNIVERZITA PALACKEHO V OLOMOUCI (CZ) 2023-06-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230192697-A1 MESYLATE SALTS OF HETEROCYCLIC CYTOKININS, COMPOSITIONS CONTAINING THESE DERIVATIVES AND USE THEREOF MAT1A, MAT2A, MAT2B LMNA 2677/4885HTT 2945/4885ALOX15 1195/4885
US-12570657-B2 Mesylate salts of heterocyclic cytokinins, compositions containing these derivatives and use thereof TYMP, TK1, DCK LMNA 2252/4885HTT 3729/4885ALOX15 4624/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.